The Impact of a Home-Based Walking Exercise Program on Heart Failure
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jan 16, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a 12-week home-based walking exercise program can help people with heart failure. Heart failure is a serious condition where the heart can’t pump blood effectively, and it affects many individuals. The researchers want to see if regular walking at home can improve patients' quality of life, reduce feelings of frailty, and lessen symptoms of depression. Participants in the trial will be divided into two groups: one group will follow the walking program after they leave the hospital, while the other group will receive standard health education. Both groups will have their progress checked at the beginning of the study and again at one and three months later.
To be eligible for this trial, participants need to be between 18 and 80 years old, have heart failure classified as moderate (not the most severe), and have the go-ahead from their doctor to join the walking program. They should also be able to walk independently and have no major cognitive issues. This trial not only aims to support the health of those with heart failure but also seeks to find a way to encourage patients to stay active at home without adding extra costs to the healthcare system. If you or someone you know is interested in participating, it could be a great opportunity to improve health and wellbeing after a hospital stay.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with heart failure classified as New York Heart Association (NYHA) Functional Class II-III by a physician.
- • Approval from the attending physician to participate in the home-based walking program after discharge.
- • Aged between 18 and 80 years.
- • Patients unable to attend outpatient cardiac rehabilitation.
- • No regular exercise habits, such as performing less than 30 minutes of aerobic exercise per week.
- • Able to walk independently without the aid of assistive devices.
- • Patients with clear consciousness, no cognitive impairment, and no history of mental illness.
- • Able to communicate in Mandarin or Taiwanese dialect.
- • Willing to participate in the study, sign the informed consent form, and comply with the home-based walking program.
- Exclusion Criteria:
- • Patients diagnosed with heart failure classified as New York Heart Association (NYHA) functional class IV by a physician.
- • Patients diagnosed with depression by a psychiatrist.
- • Patients with cognitive impairment or language communication disorders.
- • Patients who are bedridden for an extended period.
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported